c-jun overexpression, followed by c-jun phosphorylation and AP-1 activation, in response to microtubule inhibitor vinblastine, was also shown to render MCF7 breast cancer cells markedly resistant to this drug [60]. Here, FOS is linked to breast carcinoma.